Atlas Trials

RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE

Clinical trial NCT02142959 · COMPLETED

Trial details

NCT number
NCT02142959
Sponsor
Biogen
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2014-06-30
Primary completion
2015-04-30
Enrollment
187

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.